Company ISIS Pharmaceuticals, Inc. Nasdaq
Equities
US4643301090
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 99-12-31 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 88-12-31 |
B. Parshall
BRD | Director/Board Member | 69 | 91-10-31 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Joseph Klein
BRD | Director/Board Member | 62 | 05-12-12 |
B. Parshall
BRD | Director/Board Member | 69 | 91-10-31 |
Joseph Wender
BRD | Director/Board Member | 79 | 93-12-31 |
Director/Board Member | 71 | 02-04-30 | |
Michael Hayden
BRD | Director/Board Member | 72 | 18-09-23 |
Allene Diaz
BRD | Director/Board Member | 59 | 21-06-02 |
Michael Yang
BRD | Director/Board Member | 62 | Dec. 13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,751,797 | 144,488,756 ( 99.13 %) | 0 | 99.13 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |